EUCTR2008-003828-38-IT进行中（未招募）不适用
Yttrium Y90Ibritumomab Tiutexan (Zevalin)as a consolidation treatment for patients with high grade non-Hodgkin's lymphoma aged >60 years. - ND
AZIENDA OSPEDALIERA OSPEDALE S. SALVATORE0 个研究点开始时间: 2008年7月31日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Diagnosis of CD 20 positive B cell non-Hodgkin lymphoma.
- •Age > 60 years.
- •Stage > II.
- •HIV negativity.
- •Signed informed consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Age < 60 years.
- •HIV positivity;
- •Intercurrent organ damage or medical conditions which possibly would interfere with therapy.
- •Concurrent infection not controlled by medical therapy.
研究者
相似试验
招募中
不适用
Zevalin-BEAM or Zevalin as consolidation in patients with transformed lymphoma.transformed B-cell non-Hodgkin's lymphomaNL-OMON21852VUmc58
已完成
2 期
Zevalin (90Yttrium-ibritumomab tiuxetan)-BEAM and autologous stem cell transplantation or single dose 90Yttrium ibritumomab tiuxetan as consolidation of induction chemotherapy in patients with transformed non-Hodgkin*s lymphoma. ;A phase II clinical trialtransformed lymphomatransformed non-Hodgkin's lymphoma10025320NL-OMON39525Vrije Universiteit Medisch Centrum58
进行中（未招募）
不适用
90Y ibritumomab tiuxetan (Zevalin®) in patients with extra-nodal marginal zone B-cell lymphoma of Mucosa associated lymphoid tissue (MALT Lymphoma) - ZENOEUCTR2007-004289-42-GRational and Kapodistrian University of Athens40
进行中（未招募）
1 期
Phase II study of 90Y ibritumomab tiuxetan (Zevalin) in patients with untreated follicular non-Hodgkin's lymphoma. - ZEUSEUCTR2006-006808-11-ITAZIENDA OSPEDALIERA UNIVERSITARIA SAN MARTINO GENOVA
已完成
2 期
Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)LymphomaLeukemiaNCT01490723M.D. Anderson Cancer Center20